Report cover image

Global Neurology Software Market Analysis and Forecast 2026-2032

Publisher APO Research, Inc.
Published Jan 01, 2026
Length 190 Pages
SKU # APRC20822117

Description

Neurology Software plan packages, this contains individuals for individuals wellbeing records, session scheduling, billing and endurance training.

Neurology Software provides the sufferers overall health-related information to assist in wellbeing care decisions. The specialist primarily based plan provides forms similar for his or her paper counterparts however provides easy navigation, a typical paragraph and click solution, discernment and also a standardized interface that allows everyone in workout to be more practical and provide far better wellness health-related treatment towards the patient.

Viewed from the supply side, there are some manufacturers in the Neurology Software industry such as Epic, Athenahealth, Nextgen, healthfusion, Allscripts, Greenway Health, Practice Fusion, Brainlab, Kareo, Bizmatics, Advanced Data Systems, NueMD, etc. And Epic is the biggest supplier, Xttrium occupied about 14% market share.

USA is the biggest market with 42% market share, followed by Europe with 30% market share. We forecast that USA will continue to be the biggest market.

Report Includes

This report presents an overview of global market for Neurology Software, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Neurology Software, also provides the revenue of main regions and countries. Of the upcoming market potential for Neurology Software, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Neurology Software revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Neurology Software market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Neurology Software revenue, projected growth trends, production technology, application and end-user industry.

Neurology Software Segment by Company

Epic
Athenahealth
Nextgen
healthfusion
Allscripts
Greenway Health
Practice Fusion
Brainlab
Kareo
Bizmatics
Advanced Data Systems
NueMD

Neurology Software Segment by Type

Advanced Neurology EMR Software
Others

Neurology Software Segment by Application

Hospitals
College & Research Institutes
Others

Neurology Software Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neurology Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Neurology Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neurology Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Neurology Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Neurology Software company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Neurology Software revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

190 Pages
1 Market Overview
1.1 Product Definition
1.2 Neurology Software Market by Type
1.2.1 Global Neurology Software Market Size by Type, 2021 VS 2025 VS 2032
1.2.2 Advanced Neurology EMR Software
1.2.3 Others
1.3 Neurology Software Market by Application
1.3.1 Global Neurology Software Market Size by Application, 2021 VS 2025 VS 2032
1.3.2 Hospitals
1.3.3 College & Research Institutes
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Neurology Software Market Dynamics
2.1 Neurology Software Industry Trends
2.2 Neurology Software Industry Drivers
2.3 Neurology Software Industry Opportunities and Challenges
2.4 Neurology Software Industry Restraints
3 Global Growth Perspective
3.1 Global Neurology Software Market Perspective (2021-2032)
3.2 Global Neurology Software Growth Trends by Region
3.2.1 Global Neurology Software Market Size by Region: 2021 VS 2025 VS 2032
3.2.2 Global Neurology Software Market Size by Region (2021-2026)
3.2.3 Global Neurology Software Market Size by Region (2027-2032)
4 Competitive Landscape by Players
4.1 Global Neurology Software Revenue by Players
4.1.1 Global Neurology Software Revenue by Players (2021-2026)
4.1.2 Global Neurology Software Revenue Market Share by Players (2021-2026)
4.1.3 Global Neurology Software Players Revenue Share Top 10 and Top 5 in 2025
4.2 Global Neurology Software Key Players Ranking, 2024 VS 2025 VS 2026
4.3 Global Neurology Software Key Players Headquarters & Area Served
4.4 Global Neurology Software Players, Product Type & Application
4.5 Global Neurology Software Players Establishment Date
4.6 Market Competitive Analysis
4.6.1 Global Neurology Software Market CR5 and HHI
4.6.3 2025 Neurology Software Tier 1, Tier 2, and Tier 3
5 Neurology Software Market Size by Type
5.1 Global Neurology Software Revenue by Type (2021 VS 2025 VS 2032)
5.2 Global Neurology Software Revenue by Type (2021-2032)
5.3 Global Neurology Software Revenue Market Share by Type (2021-2032)
6 Neurology Software Market Size by Application
6.1 Global Neurology Software Revenue by Application (2021 VS 2025 VS 2032)
6.2 Global Neurology Software Revenue by Application (2021-2032)
6.3 Global Neurology Software Revenue Market Share by Application (2021-2032)
7 Company Profiles
7.1 Epic
7.1.1 Epic Company Information
7.1.2 Epic Business Overview
7.1.3 Epic Neurology Software Revenue and Gross Margin (2021-2026)
7.1.4 Epic Neurology Software Product Portfolio
7.1.5 Epic Recent Developments
7.2 Athenahealth
7.2.1 Athenahealth Company Information
7.2.2 Athenahealth Business Overview
7.2.3 Athenahealth Neurology Software Revenue and Gross Margin (2021-2026)
7.2.4 Athenahealth Neurology Software Product Portfolio
7.2.5 Athenahealth Recent Developments
7.3 Nextgen
7.3.1 Nextgen Company Information
7.3.2 Nextgen Business Overview
7.3.3 Nextgen Neurology Software Revenue and Gross Margin (2021-2026)
7.3.4 Nextgen Neurology Software Product Portfolio
7.3.5 Nextgen Recent Developments
7.4 healthfusion
7.4.1 healthfusion Company Information
7.4.2 healthfusion Business Overview
7.4.3 healthfusion Neurology Software Revenue and Gross Margin (2021-2026)
7.4.4 healthfusion Neurology Software Product Portfolio
7.4.5 healthfusion Recent Developments
7.5 Allscripts
7.5.1 Allscripts Company Information
7.5.2 Allscripts Business Overview
7.5.3 Allscripts Neurology Software Revenue and Gross Margin (2021-2026)
7.5.4 Allscripts Neurology Software Product Portfolio
7.5.5 Allscripts Recent Developments
7.6 Greenway Health
7.6.1 Greenway Health Company Information
7.6.2 Greenway Health Business Overview
7.6.3 Greenway Health Neurology Software Revenue and Gross Margin (2021-2026)
7.6.4 Greenway Health Neurology Software Product Portfolio
7.6.5 Greenway Health Recent Developments
7.7 Practice Fusion
7.7.1 Practice Fusion Company Information
7.7.2 Practice Fusion Business Overview
7.7.3 Practice Fusion Neurology Software Revenue and Gross Margin (2021-2026)
7.7.4 Practice Fusion Neurology Software Product Portfolio
7.7.5 Practice Fusion Recent Developments
7.8 Brainlab
7.8.1 Brainlab Company Information
7.8.2 Brainlab Business Overview
7.8.3 Brainlab Neurology Software Revenue and Gross Margin (2021-2026)
7.8.4 Brainlab Neurology Software Product Portfolio
7.8.5 Brainlab Recent Developments
7.9 Kareo
7.9.1 Kareo Company Information
7.9.2 Kareo Business Overview
7.9.3 Kareo Neurology Software Revenue and Gross Margin (2021-2026)
7.9.4 Kareo Neurology Software Product Portfolio
7.9.5 Kareo Recent Developments
7.10 Bizmatics
7.10.1 Bizmatics Company Information
7.10.2 Bizmatics Business Overview
7.10.3 Bizmatics Neurology Software Revenue and Gross Margin (2021-2026)
7.10.4 Bizmatics Neurology Software Product Portfolio
7.10.5 Bizmatics Recent Developments
7.11 Advanced Data Systems
7.11.1 Advanced Data Systems Company Information
7.11.2 Advanced Data Systems Business Overview
7.11.3 Advanced Data Systems Neurology Software Revenue and Gross Margin (2021-2026)
7.11.4 Advanced Data Systems Neurology Software Product Portfolio
7.11.5 Advanced Data Systems Recent Developments
7.12 NueMD
7.12.1 NueMD Company Information
7.12.2 NueMD Business Overview
7.12.3 NueMD Neurology Software Revenue and Gross Margin (2021-2026)
7.12.4 NueMD Neurology Software Product Portfolio
7.12.5 NueMD Recent Developments
8 North America
8.1 North America Neurology Software Revenue (2021-2032)
8.2 North America Neurology Software Revenue by Type (2021-2032)
8.2.1 North America Neurology Software Revenue by Type (2021-2026)
8.2.2 North America Neurology Software Revenue by Type (2027-2032)
8.3 North America Neurology Software Revenue Share by Type (2021-2032)
8.4 North America Neurology Software Revenue by Application (2021-2032)
8.4.1 North America Neurology Software Revenue by Application (2021-2026)
8.4.2 North America Neurology Software Revenue by Application (2027-2032)
8.5 North America Neurology Software Revenue Share by Application (2021-2032)
8.6 North America Neurology Software Revenue by Country
8.6.1 North America Neurology Software Revenue by Country (2021 VS 2025 VS 2032)
8.6.2 North America Neurology Software Revenue by Country (2021-2026)
8.6.3 North America Neurology Software Revenue by Country (2027-2032)
8.6.4 United States
8.6.5 Canada
8.6.6 Mexico
9 Europe
9.1 Europe Neurology Software Revenue (2021-2032)
9.2 Europe Neurology Software Revenue by Type (2021-2032)
9.2.1 Europe Neurology Software Revenue by Type (2021-2026)
9.2.2 Europe Neurology Software Revenue by Type (2027-2032)
9.3 Europe Neurology Software Revenue Share by Type (2021-2032)
9.4 Europe Neurology Software Revenue by Application (2021-2032)
9.4.1 Europe Neurology Software Revenue by Application (2021-2026)
9.4.2 Europe Neurology Software Revenue by Application (2027-2032)
9.5 Europe Neurology Software Revenue Share by Application (2021-2032)
9.6 Europe Neurology Software Revenue by Country
9.6.1 Europe Neurology Software Revenue by Country (2021 VS 2025 VS 2032)
9.6.2 Europe Neurology Software Revenue by Country (2021-2026)
9.6.3 Europe Neurology Software Revenue by Country (2027-2032)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
9.6.9 Spain
9.6.10 Netherlands
9.6.11 Switzerland
9.6.12 Sweden
9.6.13 Poland
10 China
10.1 China Neurology Software Revenue (2021-2032)
10.2 China Neurology Software Revenue by Type (2021-2032)
10.2.1 China Neurology Software Revenue by Type (2021-2026)
10.2.2 China Neurology Software Revenue by Type (2027-2032)
10.3 China Neurology Software Revenue Share by Type (2021-2032)
10.4 China Neurology Software Revenue by Application (2021-2032)
10.4.1 China Neurology Software Revenue by Application (2021-2026)
10.4.2 China Neurology Software Revenue by Application (2027-2032)
10.5 China Neurology Software Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
11.1 Asia Neurology Software Revenue (2021-2032)
11.2 Asia Neurology Software Revenue by Type (2021-2032)
11.2.1 Asia Neurology Software Revenue by Type (2021-2026)
11.2.2 Asia Neurology Software Revenue by Type (2027-2032)
11.3 Asia Neurology Software Revenue Share by Type (2021-2032)
11.4 Asia Neurology Software Revenue by Application (2021-2032)
11.4.1 Asia Neurology Software Revenue by Application (2021-2026)
11.4.2 Asia Neurology Software Revenue by Application (2027-2032)
11.5 Asia Neurology Software Revenue Share by Application (2021-2032)
11.6 Asia Neurology Software Revenue by Country
11.6.1 Asia Neurology Software Revenue by Country (2021 VS 2025 VS 2032)
11.6.2 Asia Neurology Software Revenue by Country (2021-2026)
11.6.3 Asia Neurology Software Revenue by Country (2027-2032)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 Taiwan
11.6.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Neurology Software Revenue (2021-2032)
12.2 SAMEA Neurology Software Revenue by Type (2021-2032)
12.2.1 SAMEA Neurology Software Revenue by Type (2021-2026)
12.2.2 SAMEA Neurology Software Revenue by Type (2027-2032)
12.3 SAMEA Neurology Software Revenue Share by Type (2021-2032)
12.4 SAMEA Neurology Software Revenue by Application (2021-2032)
12.4.1 SAMEA Neurology Software Revenue by Application (2021-2026)
12.4.2 SAMEA Neurology Software Revenue by Application (2027-2032)
12.5 SAMEA Neurology Software Revenue Share by Application (2021-2032)
12.6 SAMEA Neurology Software Revenue by Country
12.6.1 SAMEA Neurology Software Revenue by Country (2021 VS 2025 VS 2032)
12.6.2 SAMEA Neurology Software Revenue by Country (2021-2026)
12.6.3 SAMEA Neurology Software Revenue by Country (2027-2032)
12.6.4 Brazil
12.6.5 Argentina
12.6.6 Chile
12.6.7 Colombia
12.6.8 Peru
12.6.9 Saudi Arabia
12.6.10 Israel
12.6.11 UAE
12.6.12 Turkey
12.6.13 Iran
12.6.14 Egypt
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.